BMY News
Bristol-Myers Squibb Company
$61.48
-$1.52(-2.41%)
78
Overall
90
Value
90
Tech
55
Quality
Market Cap
$128.69B
Volume
9.76M
52W Range
$42.52 - $68.64
Target Price
$66.11
BMY news: the latest Bristol-Myers Squibb Company headlines, press releases and market updates, newest first.
Latest BMY News
- Berenberg Bank Reaffirms Their Buy Rating on Bloomsbury Publishing (BMY)TipRanks Auto-Generated Intelligence Newsdesk · Oct 22, 2026
- Analysts Conflicted on These Healthcare Names: Perspective Therapeutics (CATX), Bristol-Myers Squibb (BMY) and Incyte (INCY)TipRanks Newsroom · Oct 17, 2026
- Analysts Conflicted on These Healthcare Names: Perspective Therapeutics (CATX), Bristol-Myers Squibb (BMY) and Incyte (INCY)TipRanks Newsroom · Oct 17, 2026
- Analysts’ Opinions Are Mixed on These Healthcare Stocks: Lemaitre Vascular (LMAT) and Bristol-Myers Squibb (BMY)TipRanks Newsroom · Oct 13, 2026
- Truist Financial Sticks to Its Buy Rating for Bristol-Myers Squibb (BMY)TipRanks Auto-Generated Intelligence Newsdesk · Oct 13, 2026
- Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Claritev (CTEV) and Bristol-Myers Squibb (BMY)TipRanks Newsroom · Oct 13, 2026
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (BMY) and AxoGen (AXGN)TipRanks Newsroom · Oct 12, 2026
- Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Legend Biotech (LEGN) and Bristol-Myers Squibb (BMY)TipRanks Newsroom · Oct 9, 2026
- Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Veeva Systems (VEEV) and Bristol-Myers Squibb (BMY)TipRanks Newsroom · Oct 9, 2026
- Bristol-Myers Squibb (BMY) Receives a Buy from J.P. MorganTipRanks Auto-Generated Intelligence Newsdesk · Oct 8, 2026
- BMY Terminates Early Leukemia Trial, Trimming One Risky Bet From Its Oncology PipelineTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 1, 2026
- BMY Expands Real-World Cancer Data With New AUGTYRO Study in KoreaTipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 30, 2026
- The Week That Was, The Week Ahead: Macro and Markets, September 27Ran Melamed · Sep 27, 2026
- BMY’s Lung Cancer Combo Study Completion Adds Quiet Support to Its Immuno-Oncology PipelineTipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 24, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BMY | $61.48 | -2.4% | 9.76M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bristol-Myers Squibb Company Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW